Multi-domain Intervention Program for Post-stroke Bone Health in Older Adults (BOUNCE)
BOUNCE
Development and Feasibility of a Multi-domain Intervention Program for Post-stroke Bone Health (BOUNCE - Bone Health in Older adUlts' iNtervention Post aCute strokE) in Hospital Pengajar Universiti Putra Malaysia (HPUPM)
1 other identifier
interventional
70
1 country
1
Brief Summary
The goal of this feasibility randomized controlled trial is to assess the feasibility and compare the changes in bone mineral density before and after the intervention in post-stroke older adults. The main question\[s\] it aims to answer are:
- What are the baseline sociodemographic and bone health characteristics of post-stroke older adults in this study?
- Is it feasible to undertake a larger RCT to assess the effectiveness and implementation of BOUNCE program?
- Is there a difference in bone loss between groups?
- Is there a difference in bone turnover markers at baseline and at six months?
- Is there a difference in the incidence of falls and fragility fractures between groups?
- How receptive are post-stroke patients/carers to the use of food/exercise diary?
- What are the perceived motivators and barriers to implementation of BOUNCE program within real clinical settings among healthcare professionals, participants and carers?
- What is the experience of healthcare professionals, participants and carers undergoing BOUNCE program? Participants will be divided into two groups:
- Standard care
- Intervention group (BOUNCE Program) Researchers will compare both groups to see any changes in the bone mineral density and bone turnover markers before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 7, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2025
CompletedJanuary 25, 2024
January 1, 2024
1.8 years
March 7, 2023
January 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Areal Bone Mineral Density (BMD) at the Neck of Femur as measured by Hologic Dual X-ray Absorptiometry in g/cm2
To examine the difference in Areal BMD change pre and post-intervention between groups
At baseline and month-6
Secondary Outcomes (8)
Recruitment uptake
Throughout study period of average 1 year
Change in the level Bone Turnover Markers (BTM) as assessed by C-Telopeptide-Cross-Linked Type I Collagen (CTx) in ng/ml and Procollagen Type I N-Terminal Propeptide (PINP) in ng/ml
At baseline and month-6
Retention
Assessment at month-4 and month-6
Treatment adherence
Assessment at month-4 and month-6
Acceptability
Assessment at month-4 and month-6
- +3 more secondary outcomes
Study Arms (2)
Standard Care
ACTIVE COMPARATORStandard post-stroke care
Intervention
EXPERIMENTALBOUNCE Program
Interventions
Intervention arm: Bone-building exercises will be incorporated into the standard post-stroke exercises, as well as Nutritional intervention consisting of individualized diet plan based on calorie requirement, high-quality protein intake, vitamin D, Calcium and micronutrients with a one-to-one virtual session.
Eligibility Criteria
You may qualify if:
- Aged 50 years old and older
- Neurologist diagnosed acute stroke within 90 days
- Has baseline biochemical test upon admission to the ward
- Able to undergo DXA scan
- Modified Rankin Score of 2 to 3
- Able to walk with or without aids
You may not qualify if:
- Known underlying malignancy
- Known major depression or severe psychological illness
- Known chronic kidney disease stage 3b (eGFR \<45ml/min/1.73m2) or more
- Taken oral glucocorticoids therapy for at least three months
- Presence of cognitive impairment (ECAQ \<7)
- Presence of coronary artery syndrome or congestive cardiac failure
- Presence of an uncontrolled respiratory condition
- Underlying malabsorption syndrome
- Underlying conditions other than stroke that impairs mobility (eg Severe Osteoarthritis, Parkinson's Disease, Multiple sclerosis)
- Known osteoporosis or fragility fracture
- Serum phosphate or calcium abnormalities
- Discharge to a nursing home or rehabilitation centre
- Already a participant in another trial/study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Sultan Abdul Aziz Shah
Serdang, Selangor, 43400, Malaysia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sazlina Shariff-Ghazali, PhD
Universiti Putra Malaysia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 7, 2023
First Posted
July 11, 2023
Study Start
March 1, 2023
Primary Completion
November 30, 2024
Study Completion
August 31, 2025
Last Updated
January 25, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share